Trial
NCT02261805
A Phase I/II Study of Ganetespib in Combination With Doxorubicin
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Georgetown University
Collaborators
Synta Pharmaceuticals Corp.
Condition
Cancer
Intervention
Ganetespib
Why stopped
Company terminated drug support
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-23